The level of PGRMC2 protein was evaluated by immunohistochemistry in human endometrial samples during the proliferative and secretory phases of the menstrual cycle, as well as in endometrial cancer specimens (Figure 1). This evidence concerns the gene PGRMC2 and endometrial cancer.